Flutiform: novel asthma combination inhaler

Flutiform (formoterol fumarate/fluticasone propionate) is a fixed-dose combination metered-dose inhaler indicated for the regular treatment of asthma where a long-acting ß2 agonist (LABA) in combination with an inhaled corticosteroid is appropriate.

by
Flutiform can be used in patients who are not adequately controlled on an inhaled corticosteroid and an ‘as required’ inhaled short-acting ß2 agonist, and those who are adequately controlled on both an inhaled corticosteroid and a LABA.
Flutiform can be used in patients who are not adequately controlled on an inhaled corticosteroid and an ‘as required’ inhaled short-acting ß2 agonist, and those who are adequately controlled on both an inhaled corticosteroid and a LABA.

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package